Application-based Endoscopes segmentation structures demand across gastroenterology, urology, gynecology, neurology, orthopedics, ENT, cardiology, pulmonology, and general surgery. Gastroenterology dominates, accounting for roughly 32% of 2023 global revenues propelled by rising colorectal-cancer screening and therapeutic ERCP volumes; hospitals prioritize high-definition colonoscopes, inflating average selling prices. Urology follows with ~18%, lifted by growing prostate procedures and single-use cystoscopes that mitigate cross-contamination costs. Orthopedics and neurology together claim ~15%, where 4K arthroscopes and minimally invasive neurosurgery tools command premium pricing despite lower unit sales. Cardiology remains price-sensitive, yet optical coherence endoscopes for intravascular imaging widen the segment. Pulmonology is accelerating fastest, spurred by robotic bronchoscopy reimbursements. Gynecology, ENT, and general surgery exhibit fragmented adoption; ambulatory surgery centers shift toward value-tier HD systems, constraining revenue growth but widening installed base for service contracts.